Dr. Lal Pathlabs is currently trading at Rs. 1851.40, up by 16.15 points or 0.88% from its previous closing of Rs. 1835.25 on the BSE.
The scrip opened at Rs. 1849.95 and has touched a high and low of Rs. 1871.70 and Rs. 1835.15 respectively. So far 9255 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 10 has touched a 52 week high of Rs. 2870.00 on 28-Apr-2022 and a 52 week low of Rs. 1781.15 on 14-Mar-2023.
Last one week high and low of the scrip stood at Rs. 1929.85 and Rs. 1781.15 respectively. The current market cap of the company is Rs. 15433.06 crore.
The promoters holding in the company stood at 55.05%, while Institutions and Non-Institutions held 31.99% and 12.96% respectively.
Dr. Lal PathLabs has selected Kyndryl, the world’s largest IT infrastructure services provider, to manage its IT infrastructure stack, including both the on-premises IT environment and cloud infrastructure across multiple hyperscaler cloud service providers. Post onboarding, Kyndryl has been instrumental in managing the multiple cloud platforms that play a key role in Dr Lal PathLabs’ digital transformation initiatives to drive business growth.
Kyndryl provides a single pane view of server utilization, service requests, ticketing lifecycle, incident analysis, and also recommends proactive remediation. Offering a unified view of their infrastructure utilization on-premises and across multiple public cloud environments has improved service availability and helped Dr. Lal Pathlabs reduce IT incidents by a substantial margin. Kyndryl has also integrated compliance checks such as inventory management, patching, and security health, which have helped achieve continuous compliance within Dr. Lal PathLabs’ cloud environment and security posture.
Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.